应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
FBIO Fortress Biotech Inc.
休市中 12-05 16:00:00 EST
2.83
+0.08
+2.91%
盘后
2.86
+0.03
+1.06%
19:29 EST
最高
2.87
最低
2.77
成交量
28.63万
今开
2.83
昨收
2.75
日振幅
3.48%
总市值
8,784万
流通市值
6,654万
总股本
3,104万
成交额
81.06万
换手率
1.22%
流通股本
2,351万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Fortress Biotech:Cyprium将在NDA批准后保留对任何PRV的所有权,并将获得版税以及高达1.29亿美元的里程碑付款
美股速递 · 11-17
Fortress Biotech:Cyprium将在NDA批准后保留对任何PRV的所有权,并将获得版税以及高达1.29亿美元的里程碑付款
Fortress Biotech Inc.:在11月14日,Sentynl通知Cyprium已重新提交Cutx-101的NDA给FDA
美股速递 · 11-17
Fortress Biotech Inc.:在11月14日,Sentynl通知Cyprium已重新提交Cutx-101的NDA给FDA
Fortress Biotech及其子公司Urica Therapeutics宣布Crystalys Therapeutics全球III期Dotinurad治疗痛风临床试验首位患者接受治疗
美股速递 · 10-21
Fortress Biotech及其子公司Urica Therapeutics宣布Crystalys Therapeutics全球III期Dotinurad治疗痛风临床试验首位患者接受治疗
Fortress Biotech Inc.及其子公司Urica Therapeutics宣布Crystalys Therapeutics完成2.05亿美元A轮融资
美股速递 · 10-01
Fortress Biotech Inc.及其子公司Urica Therapeutics宣布Crystalys Therapeutics完成2.05亿美元A轮融资
加载更多
公司概况
公司名称:
Fortress Biotech Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Fortress Biotech, Inc.于2006年6月28日在特拉华州注册成立。该公司是一家生物制药公司,专注于收购和推进资产,通过产品收入、股权持有以及股息和特许权使用费收入流为股东提升长期价值。
发行价格:
--
{"stockData":{"symbol":"FBIO","market":"US","secType":"STK","nameCN":"Fortress Biotech Inc.","latestPrice":2.83,"timestamp":1764968400000,"preClose":2.75,"halted":0,"volume":286257,"hourTrading":{"tag":"盘后","latestPrice":2.86,"preClose":2.83,"latestTime":"19:29 EST","volume":930,"amount":2650.84,"timestamp":1764980948683},"delay":0,"floatShares":23511081,"shares":31037937,"eps":-0.953861,"marketStatus":"休市中","change":0.08,"latestTime":"12-05 16:00:00 EST","open":2.83,"high":2.8658,"low":2.77,"amount":810621.9428346,"amplitude":0.034836,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.953861,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":2.75,"preHourTrading":{"tag":"盘前","latestPrice":2.89,"preClose":2.75,"latestTime":"09:28 EST","volume":423,"amount":1217.9268954,"timestamp":1764944918267},"postHourTrading":{"tag":"盘后","latestPrice":2.86,"preClose":2.83,"latestTime":"19:29 EST","volume":930,"amount":2650.84,"timestamp":1764980948683},"volumeRatio":0.7202568044267832,"impliedVol":1.4514,"impliedVolPercentile":0.84},"requestUrl":"/m/hq/s/FBIO","defaultTab":"news","newsList":[{"id":"1115885695","title":"Fortress Biotech:Cyprium将在NDA批准后保留对任何PRV的所有权,并将获得版税以及高达1.29亿美元的里程碑付款","url":"https://stock-news.laohu8.com/highlight/detail?id=1115885695","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115885695?lang=zh_cn&edition=full","pubTime":"2025-11-17 20:37","pubTimestamp":1763383035,"startTime":"0","endTime":"0","summary":"Fortress Biotech:Cyprium将在NDA批准后保留对任何PRV的所有权,并将获得版税以及高达1.29亿美元的里程碑付款","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBIO","BK4139"],"gpt_icon":0},{"id":"1126564189","title":"Fortress Biotech Inc.:在11月14日,Sentynl通知Cyprium已重新提交Cutx-101的NDA给FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=1126564189","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126564189?lang=zh_cn&edition=full","pubTime":"2025-11-17 20:33","pubTimestamp":1763382814,"startTime":"0","endTime":"0","summary":"Fortress Biotech Inc.:在11月14日,Sentynl通知Cyprium已重新提交Cutx-101的NDA给FDA","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBIO","BK4139"],"gpt_icon":0},{"id":"1130939272","title":"Fortress Biotech及其子公司Urica Therapeutics宣布Crystalys Therapeutics全球III期Dotinurad治疗痛风临床试验首位患者接受治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1130939272","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130939272?lang=zh_cn&edition=full","pubTime":"2025-10-21 20:31","pubTimestamp":1761049870,"startTime":"0","endTime":"0","summary":"Fortress Biotech及其子公司Urica Therapeutics宣布,Crystalys Therapeutics正在进行的全球III期Dotinurad治疗痛风的临床试验首位患者已完成用药。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBIO"],"gpt_icon":0},{"id":"1158296044","title":"Fortress Biotech Inc.及其子公司Urica Therapeutics宣布Crystalys Therapeutics完成2.05亿美元A轮融资","url":"https://stock-news.laohu8.com/highlight/detail?id=1158296044","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158296044?lang=zh_cn&edition=full","pubTime":"2025-10-01 20:06","pubTimestamp":1759320378,"startTime":"0","endTime":"0","summary":"Fortress Biotech Inc.及其子公司Urica Therapeutics宣布Crystalys Therapeutics完成2.05亿美元A轮融资","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBIO","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fortressbiotech.com","stockEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":0.1411},{"period":"3month","weight":-0.2372},{"period":"6month","weight":0.415},{"period":"1year","weight":0.3771},{"period":"ytd","weight":0.3975}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fortress Biotech, Inc.于2006年6月28日在特拉华州注册成立。该公司是一家生物制药公司,专注于收购和推进资产,通过产品收入、股权持有以及股息和特许权使用费收入流为股东提升长期价值。","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":0.087937},{"month":2,"riseRate":0.6,"avgChangeRate":0.010779},{"month":3,"riseRate":0.4,"avgChangeRate":-0.009436},{"month":4,"riseRate":0.4,"avgChangeRate":-0.006403},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.025034},{"month":6,"riseRate":0.272727,"avgChangeRate":-0.018965},{"month":7,"riseRate":0.545455,"avgChangeRate":-0.008162},{"month":8,"riseRate":0.545455,"avgChangeRate":0.05815},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.057104},{"month":10,"riseRate":0.272727,"avgChangeRate":-0.163485},{"month":11,"riseRate":0.818182,"avgChangeRate":0.114632},{"month":12,"riseRate":0.545455,"avgChangeRate":0.049683}],"exchange":"NASDAQ","name":"Fortress Biotech Inc.","nameEN":"Fortress Biotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fortress Biotech Inc.(FBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fortress Biotech Inc.(FBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fortress Biotech Inc.,FBIO,Fortress Biotech Inc.股票,Fortress Biotech Inc.股票老虎,Fortress Biotech Inc.股票老虎国际,Fortress Biotech Inc.行情,Fortress Biotech Inc.股票行情,Fortress Biotech Inc.股价,Fortress Biotech Inc.股市,Fortress Biotech Inc.股票价格,Fortress Biotech Inc.股票交易,Fortress Biotech Inc.股票购买,Fortress Biotech Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fortress Biotech Inc.(FBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fortress Biotech Inc.(FBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}